DETAILS, FICTION AND WHO MAKES COPYRIGHT SEMAGLUTIDE

In March 2025, the company introduced new ideas for a direct-to-client providing of its Wegovy weight loss drug. The company established a new pharmacy, referred to as NovoCare, which would demand consumers $499 a month for access to the drug, a lot less than 50 percent the expense of the drug via other pharmaceutical distribution networks.[53]Than